RARE DISEASERESEARCH ATLAS

ORPHA:83593

Western equine encephalitis

low confidenceDisorder

Also known as: Western equine encephalomyelitis

Publications

3,353

Trials

3

Interventional, condition-specific

Researchers

1,399

Distinct authors in sample

Gene link

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

An acute arboviral infection caused by an alphavirus of the Togaviridae family transmitted by an infected mosquito, that more frequently affects children and that is characterized by the presence of mild flu-like symptoms (fever, chills, headache, nausea, vomiting, and anorexia) but that can progress to weakness, altered mental status, photophobia, mental confusion, , somnolence, coma and/or even death. The disease can leave neurological sequelae, mainly in infants and children, such as , spasticity or behavioral disorders.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

Western equine encephalitis virus caused infectious encephalitis · Western equine encephalitis virus infectious encephalitis

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    3,353 matched papers (1,188 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    3 matched on ClinicalTrials.gov

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

3,353

3,353 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

3,353 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

1,188 in the last 10 years · low confidence

Phrase hits: 3,353 · MeSH hits: 3

Open Europe PMC search

Who's working on it?

1,399

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Weaver SC9 papers · 2025

    Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.

    Papers in Europe PMC
  2. 02
    Kehn-Hall K6 papers · 2026

    National Center for Biodefence and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.

    Papers in Europe PMC
  3. 03
    Klimstra WB6 papers · 2026

    The Center for Vaccine Research and Department of Immunology, The University of Pittsburgh, Pittsburgh, PA 15261, USA.

    Papers in Europe PMC
  4. 04
    Zhang L6 papers · 2026

    Department of Infectious Diseases, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.

    Papers in Europe PMC
  5. 05
    Chen Y5 papers · 2026

    Laboratory of Advanced Biotechnology, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, China.

    Papers in Europe PMC
  6. 06
    Diamond MS5 papers · 2026

    Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.

    Papers in Europe PMC
  7. 07
    Pérez R5 papers · 2025

    Sección Genética Evolutiva, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay. rperez@fcien.edu.uy.

    Papers in Europe PMC
  8. 08
    Ahuka-Mundeke S4 papers · 2026

    Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.

    Papers in Europe PMC
  9. 09
    Ariën KK4 papers · 2026

    Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. Electronic address: karien@itg.be.

    Papers in Europe PMC
  10. 10
    Casseb LMN4 papers · 2026

    Veterinarian, DSc., Seção de Arbovirologia e Febres Hemorrágicas, IEC, Ananindeua, PA, Brazil.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

3

interventional trials for this specific condition

3 interventional trials matched this specific condition name; none in our sample are currently recruiting.

Data as of 27 July 2026

3 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 85.1th percentile).

low confidence · 85.1th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

3 interventional trials matched after quoted-phrase search and title/condition post-filter.

No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Western equine encephalitis" OR "Western equine encephalomyelitis" OR "Western equine encephalitis virus caused infectious encephalitis" OR "Western equine encephalitis virus infectious encephalitis"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Encephalomyelitis, Western Equine

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Western equine encephalitis" OR "Western equine encephalomyelitis" OR "Western equine encephalitis virus caused infectious encephalitis" OR "Western equine encephalitis virus infectious encephalitis" OR "Encephalomyelitis, Western Equine"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 3 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (3353) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T02:39:25.882Z